Transplant Diagnostics Market To Expand At A Noteworthy CAGR of 7.8% During 2018-2023

The Global Transplant Diagnostics Market is touted to scale the valuation of USD 2,074.65 million during the forecast period (2018-2023), reveals insightful reports of Market Research Future (MRFR).

Pune, India - August 7, 2018 /MarketersMedia/ —

Transplant Diagnostics Market Overview:

Transplant diagnostics are the tests that are carried out to check the compatibility between the organ donor and recipient before or after the organ transplant. According to the report that has been recently published by Market Research Future (MRFR), the global transplant diagnostics market is anticipated to expand at a noteworthy CAGR of 7.8 % during the forecast period of 2018-2023.

Market Drivers and Restraints:

With the upsurge in population and rapid change in lifestyle, the prevalence of chronic diseases and critical illnesses is increasing, leading to the rise in incidences of organ failure. The increasing demand for diagnostic procedures for carrying out organ transplant is one of the major factors driving the global transplant diagnostics market.

The rapid incorporation of advanced technologies for diagnostic processes in order to ensure accuracy of the procedures is fueling the expansion of the global transplant diagnostics market. The increasing prevalence of diseases that cause organ failure such as congenital heart diseases, coronary artery diseases, cancer, renal diseases, and others are resulting in the increased demand for transplant diagnostics leading to the significant growth of the global transplant diagnostics market.

Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/1324

The high need for improved and sophisticated diagnostic tools owing to the complexities and risks related to the transplant procedures is creating large number of opportunities for the players to invest in the global transplant diagnostics market, which in turn is driving the global transplant diagnostics market towards higher verticals. The proliferation in geriatric population and increasing popularity of cosmetic and reconstructive surgeries are likely to fuel the expansion of the global transplant diagnostics market during the forecast period.

However, the strict regulatory framework regarding organ donation and organ harvesting and lack of awareness among the population of underdeveloped regions are likely to act as restraints on the growth of the global transplant diagnostics market.

Top Players List:

The leading players in the global transplant diagnostics market that are profiled in the report published by MRFR are Thermo Fisher Scientific Inc., F. Hoffmann La Roche Ltd., Bio-Rad Laboratories, Inc., QIAGEN N.V., Illumina, Inc., bioMérieux S.A., Becton Dickinson and Company, and others.

Market Segmentation:

The global transplant diagnostics market has been segmented on the basis of product and services, screening type, organ type, application type and end-users. Based on product and services, the transplant diagnostics market is segmented into instruments, reagents and consumables, software and services. Based on screening type, the transplant diagnostics market is segmented into pre-transplant screening and post-transplant screening.

 Based on organ type, the transplant diagnostics market is segmented into kidney, pancreas, liver, heart, lungs and others. Based on application type, the transplant diagnostics market is segmented into research applications, diagnostic applications and others. Based on end-users, the transplant diagnostics market is segmented into commercial service providers, hospital and transplant centers, research laboratories and academic institutes, and others.

Regional Analysis:

Geographically, the Global Transplant Diagnostics Market is segmented into four major regions such as Americas, Europe, Asia Pacific and the Middle East and Africa. Among these regions, the Americas are dominating the global transplant diagnostics market owing to the increasing prevalence of chronic diseases leading to organ failure and rapid technological development aiding in the automation of the diagnostic procedures in the healthcare sector of this region.

The Europe region accounts for the second largest share in the global transplant diagnostics market. The transplant diagnostics market in this region is driven by the easy adoption of advanced healthcare technologies, active involvement of the government for spreading awareness, and availability of donated organs due to the initiatives that were taken by the European Commission for organ harvesting. 

The Asia Pacific region is anticipated to project significant growth in the global transplant diagnostics market due to the rapid increase in geriatric population and increasing incidences of organ failure in this region. The high investment in stem cell technology for organ development and in-vitro tissue are some of the crucial factors that are driving the transplant diagnostics market in this region.

The lack of awareness, less technological penetration and poor healthcare infrastructure in the underdeveloped areas of the Middle East and Africa region are hampering the growth of the global transplant diagnostics market.

Competitive Analysis:

The increasing incidences of organ failure have generated a high demand for efficient diagnostic procedures which has created a huge opportunity for the players to invest in the global transplant diagnostics market. The players in the global market are focusing on the expansion of their business by increasing the research and development expenditure for new product launch in the global transplant diagnostics market. The strategic mergers and acquisitions are aiding the players to sustain in the highly competitive environment of the global transplant diagnostics market.

In May 2018, CareDx, a U.S.-based molecular diagnostics company, has announced the signing of licensing and commercialization agreement with Illumina, a provider of next-generation sequencing solutions. CareDx is now the exclusive worldwide distributor of Illumina’s TruSight HLA v1 and v2 product lines which will be used for bone marrow transplantation diagnostic testing and solid organ transplantation diagnostic testing.

Get Discount @ https://www.marketresearchfuture.com/check-discount/1324

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: [email protected]
Organization: Market Research Future
Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: +1 646 845 9312

Source URL: https://marketersmedia.com/transplant-diagnostics-market-to-expand-at-a-noteworthy-cagr-of-7-8-during-2018-2023/389988

For more information, please visit https://www.marketresearchfuture.com/reports/transplant-diagnostics-market-1324

Source: MarketersMedia

Release ID: 389988